FIELD: medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to an antiviral agent as gel. Agent comprises human leukocyte interferon and 2-% solution of styrene copolymer and maleic anhydride as gel-forming base in the following ratio of the agent components, in 1 g of the agent: concentrated interferon, 5000-10000 IU; nipagin, 0.002-0.004 g and a base, the balance. Proposed agent possesses high activity, nontoxic and possesses antiviral, immunomodulating, anti-inflammatory and regenerative effects and can be used in ophthalmology, dermatology, gynecology and surgery for topical using and in treatment of viral diseases.
EFFECT: valuable medicinal properties of agent.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRUS AGENT WITH HUMAN LEUKOCYTIC HUMAN INTERFERON BASED ON CHITOSAN SUCCINATE | 2009 |
|
RU2404796C1 |
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| METRONIDASOL-CONTAINING PREPARATION FOR TREATING EYE DISEASES | 2003 |
|
RU2235536C1 |
| AGENT FOR ACCELERATING WOUND HEALING | 2003 |
|
RU2239415C1 |
| WOUND-HEALING BIOPREPARATION AS GEL | 2006 |
|
RU2322996C2 |
| AGENT FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASE USING METRONIDAZOL AND OXYMETHYLURACIL | 2003 |
|
RU2241455C1 |
| OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2438650C1 |
| OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2456978C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
| ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
